http://www.burrillreport.com/index.html en-us Copyright 2007 The Journal Of Life Science Sun, 14 Mar 2010 23:32:54 PDT http://www.burrillreport.com/index.html When regulators give speeches or interviews that announce new regulatory expectations, it is never a good idea – and least of all when the policy implicates First Amendment values and involves potential criminal enforcement. The issue at hand is the pharmaceutical industry’s use of social media – an issue where there is already significant confusion.  And now, Peter J. Pitts writes, thanks to comments from an FDA official, there’s more. Peter J. Pitts Wed, 17 Feb 2010 00:00:00 PST http://www.burrillreport.com/index.html